Ken Sato

15PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesCancer diagnosisMolecular medicineNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 27, 2023
A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases.

Ken Sato, Atsushi Naganuma, Tamon Nagashima

|Dec 30, 2022
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.

Ryosuke Nakamura, Noriaki Arakawa, Yoichi Tanaka

|Jul 14, 2022
Frequency of null genotypes of glutathione S-transferase M1 and T1 in Japanese patients with drug-induced liver injury.

Kazuya Maeda, Hajime Takikawa, Mitsuhiko Aiso

|Apr 13, 2022
Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy.

Ken Sato, Yuichi Yamazaki, Yuki Kanayama

Pageof 3